Top Markets
#1 Islamic Coin Islamic Coin +151.26%
#2 Akedo Akedo +76.66%
#3 Glidr Glidr +51.75%
#4 Velvet Velvet +50.79%
#5 DOVU DOVU +48.24%
#6 Cross Cross +35.04%
#7 Black Phoenix Black Phoenix +33.93%
#8 Cap Cap +19.07%
#9 DoubleZero DoubleZero +16.25%
#10 Movement Movement +9.74%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Classifica tra le azioni #39102
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Prezzo delle azioni
$0.02243487
Ultima sincronizzazione: 2025-06-04
Capitalizzazione di mercato
$650.09K
Variazione (1 giorno)
0.39%
Variazione (1 anno)
0.00%
Paese
SE
Scambia Lipidor AB (publ) (LIPI)

Categoria

Healthcare
EPS per Lipidor AB (publ) (LIPI)
EPS al December 2024 TTM: $-0.01
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Lipidor AB (publ), l’EPS attuale della società (TTM) è $-0.01. Alla fine del 2023, la società aveva un EPS di $-0.04 una diminuzione rispetto a rispetto a quello del 2022, che era di $-0.14.
Storico EPS per Lipidor AB (publ) da 2016 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.01 -92.68%
2024 0.00 -92.68%
2023 $-0.04 -70.93%
2022 $-0.14 66.50%
2021 $-0.08 2.38%
2020 $-0.08 9.75%
2019 $-0.07 54.89%
2018 $-0.05 125.96%
2017 $-0.02 -29.97%
2016 $-0.03 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -328,121.98%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -95,154.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -39,110.99%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -224,154.95%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -13,946.15%
US